Vanda Pharmaceuticals

This study tested a drug called imsidolimab in 8 adults with active generalized pustular psoriasis (GPP), a rare and painful skin condition that causes widespread pus-filled blisters. The goal was to see if the drug could safely reduce symptoms like redness, swelling, and pustule…

This study tested whether a new drug, VHX-896, works similarly in the body to the approved medication iloperidone. 26 adults with stable schizophrenia or bipolar I disorder took both drugs to compare their effects and safety. The goal was to see if VHX-896 could be a future treat…

This study tested a new drug called imsidolimab in 59 adults with palmoplantar pustulosis, a skin condition causing painful pus-filled blisters on the palms and soles. The goal was to see if the drug could reduce the severity of the blisters and scaling. Results suggest the drug …

This study tested a drug called imsidolimab (ANB019) in 149 adults with hidradenitis suppurativa, a chronic skin condition that causes painful boils and abscesses. Participants received either the drug or a placebo for 16 weeks. The main goal was to see if the drug reduced the nu…

This study tested whether tradipitant can reduce nausea and vomiting caused by GLP-1 weight-loss drugs. 124 healthy overweight or obese volunteers took either tradipitant or a placebo. The goal was to see if tradipitant helps people stick with their weight-loss treatment without …

This study tested a new drug called imsidolimab for people with moderate to severe acne. 123 participants received either the drug or a placebo. The main goal was to see if the drug reduced the number of pimples and inflamed spots on the face after 12 weeks.

This study tested whether VSJ-110 eye drops can reduce eye itching and redness caused by allergies. 47 adults received either the eye drops or a placebo, then were exposed to an allergen. The main goals were to see if the drops relieved symptoms better than placebo and were safe …